We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Demand for nanotechnology medical products will grow by more than 17 percent annually to reach $53 billion in 2011, according to a recent report from The Freedonia Group.
Perrigo is recalling 11 million bottles of 500-mg acetaminophen caplets after its metal detectors revealed small metal fragments in some of the product, which it manufactured and distributed under various store brands.
Despite a 28 percent increase in profits and an 11 percent rise in sales, AstraZeneca will cut approximately 3,000 jobs to help with anticipated losses from generic competition, the company announced.
Federal investigators from the FDA’s Office of Criminal Investigations unexpectedly showed up Feb. 14 to conduct a full-scale search of Ranbaxy offices and a manufacturing plant in New Jersey, company sources said.
Bayer is cutting 6,100 jobs as part of its acquisition of Schering AG, the company announced. The cuts, which will eliminate about 5.5 percent of Bayer’s work force, are a necessary part of minimizing the overlap between the two companies, Bayer said.
The International Electronics Manufacturing Initiative (iNEMI) has started a "Medical Components Reliability Specifications Project" to develop testing and guidelines for electronic components and circuit boards used in medical devices.
Separate earnings reports released by Barr and Watson show expenses and other charges related to acquisition activity were key factors that drove earnings downward for both companies in 2006.
Nonsteroidal anti-inflammatory drugs (NSAIDs), with the exception of aspirin, increase the risk of heart attack and stroke, the American Heart Association (AHA) said, recommending that these drugs not be used as the first line of treatment for patients at risk for heart disease.